EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies

Yanan Xiao iD, Yifang Chen, Anne Pietzner, Ulf Elbelt iD, Zhimin Fan, Karsten H Weylandt iD

Nutrients · 24.05.2024 · 16 (11) · 1610

DOI: 10.3390/nu16111610 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Nutrients, online erschienen am 24.05.2024. Verfasst von Yanan Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Pingxiang People's Hospital, Gannan Medical University, Pingxiang 337000, China. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Coronary Disease, Observational Studies as Topic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-chain n-3 polyunsaturated fatty acid (PUFA) supplementation has shown potential benefits in the prevention of coronary heart disease (CHD); however, the impact of omega-3 fatty acid levels on CHD risk remains a subject of debate. Here, we aimed to investigate the association between n-3 PUFA levels and the risk of CHD, with particular reference to the subtypes of n-3 PUFA.

Methods

Prospective studies and retrospective case-control studies analyzing n-3 PUFA levels in CHD, published up to 30 July 2022, were selected. A random effects meta-analysis was used for pooled assessment, with relative risks (RRs) expressed as 95% confidence intervals (CIs) and standardized mean differences expressed as weight mean differences (WMDs). Subgroup and meta-regression analyses were conducted to assess the impact of n-3 PUFA exposure interval on the CHD subtype variables of the study.

Results

We included 20 prospective studies (cohort and nested case-control) and 16 retrospective case-control studies, in which n-3 PUFAs were measured. Higher levels of n-3 PUFAs (ALA, EPA, DPA, DHA, EPA + DHA, total n-3 PUFAs) were associated with a reduced risk of CHD, with RRs (95% CI) of 0.89 (0.81, 0.98), 0.83 (0.72, 0.96); 0.80 (0.67,0.95), 0.75 (0.64, 0.87), 0.83 (0.73, 0.95), and 0.80 (0.70, 0.93), respectively, p < 0.05. CHD patients had significantly lower n-3 PUFA levels compared to healthy controls (p < 0.05). In the subgroup analysis, a significant inverse trend was found for both fatal CHD and non-fatal CHD with n-3 PUFA (EPA + DHA) levels. Also, the link between n-3 PUFA levels in erythrocytes with total CHD was generally stronger than other lipid pools. Conclusions: n-3 PUFAs are significantly related to CHD risk, and these findings support the beneficial effects of n-3 PUFAs on CHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, Omega-3Coronary DiseaseObservational Studies as TopicHumansFemaleRetrospective StudiesMaleCase-Control StudiesMiddle AgedProspective StudiesDietary SupplementsAgedRisk Factors

Stichwörter der Autor:innen

cardiovascular diseasecoronary heart diseasedocosapentaenoic acideicosapentaenoic acidn-3 polyunsaturated fatty acid

Substanzen

Fatty Acids, Omega-3

Autor:innen und Institutionen

  • Department of Medicine, Pingxiang People's Hospital, Gannan Medical University, Pingxiang 337000, China.
  • Division of Medicine, Department of Gastroenterology, Metabolism and Oncology, University Hospital Ruppin-Brandenburg, Brandenburg Medical School, 16816 Neuruppin, Germany.
  • Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, 14467 Potsdam, Germany.
  • Medical Department, Division of Psychosomatic Medicine, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, German…
  • Department of Cardiology, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Capital Medical University, Beijing 100029, China.

ORCID-Profile: Yanan Xiao, Ulf Elbelt, Karsten H Weylandt

Zitieren

APA

Xiao, Y., Chen, Y., Pietzner, A., Elbelt, U., Fan, Z., & Weylandt, K. H. (2024). Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies. Nutrients, 16(11), 1610. https://doi.org/10.3390/nu16111610

Vancouver

Xiao Y, Chen Y, Pietzner A, Elbelt U, Fan Z, Weylandt KH. Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies. Nutrients. 2024;16(11):1610. doi:10.3390/nu16111610

BibTeX
@article{Xiao2024,
  author = {Xiao, Yanan and Chen, Yifang and Pietzner, Anne and Elbelt, Ulf and Fan, Zhimin and Weylandt, Karsten H},
  title = {Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {1610},
  doi = {10.3390/nu16111610}
}
Kostenlos starten →